Authors: SCHULMAN H LAUFER L YERUSHALMI B SOFER S HERTZANU YS

Citation: H. Schulman et al., HEMORRHAGIC-SHOCK AND ENCEPHALOPATHY SYNDROME CRANIAL CT FEATURES, Radiology, 209P, 1998, pp. 1491-1491

Authors: YERUSHALMI B RAZ R BLONDHEIM O SHUMOV E KOREN R DAGAN R

Citation: B. Yerushalmi et al., SAFETY AND IMMUNOGENICITY OF A NOVEL MAMMALIAN CELL-DERIVED RECOMBINANT HEPATITIS-B VACCINE CONTAINING PRE-S1 AND PRE-S2 ANTIGENS IN NEONATES, The Pediatric infectious disease journal, 16(6), 1997, pp. 587-592

Authors: YERUSHALMI B RAZ R BLONDHEIM O SHUMOV E KOREN R DAGAN R

Citation: B. Yerushalmi et al., SAFETY AND IMMUNOGENICITY OF A NOVEL MAMMALIAN CELL-DERIVED RECOMBINANT HEPATITIS-B VACCINE CONTAINING PRE-S1 AND PRE-S2 ANTIGENS IN NEONATES (VOL 16, PG 587, 1997), The Pediatric infectious disease journal, 16(11), 1997, pp. 1037-1037

Authors: SOFER S YERUSHALMI B SHAHAK E BERENSTEIN T SCHULMAN H

Citation: S. Sofer et al., POSSIBLE ETIOLOGY OF HEMORRHAGIC-SHOCK AND ENCEPHALOPATHY SYNDROME INTHE NEGEV AREA OF ISRAEL, Archives of Disease in Childhood, 75(4), 1996, pp. 332-334